Is BSEM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BSEM. It does not provide personalized investment advice.

BSEM (BIOSTEM TECHNOLOGIES INC) Stock Analysis - Financials

BIOSTEM TECHNOLOGIES INC (BSEM) is a publicly traded the market company. As of August 7, 2026, BSEM trades at $4.07 with a market cap of $0 and a P/E ratio of 0.00. BSEM moved -8.96% today. Year to date, BSEM is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces BSEM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BSEM's key financials?

BSEM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BSEM recently traded at $4.07. Market cap is $0. P/E ratio is 0.00. Revenue is $0.

BSEM Key Metrics

Key financial metrics for BSEM
Metric	Value
Price	$4.07
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$0.00
52-Week Low	$0.00
Volume	253.79K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

BSEM Analyst Consensus

1 analysts cover BSEM: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.

Common questions about BSEM

What are BSEM's key financials?: BSEM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BSEM recently traded at $4.07. Market cap is $0. P/E ratio is 0.00. Revenue is $0.
Is BSEM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BSEM. It does not provide personalized investment advice.